Lineage Cell Therapeutics Inc. held its annual meeting of shareholders on June 26, 2025. During the meeting, shareholders approved an amendment to the company's 2021 Equity Incentive Plan, increasing the number of common shares available for issuance by 19,500,000.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lineage Cell Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000950170-25-093007), on July 02, 2025, and is solely responsible for the information contained therein.